Search

everythinglearnresearchcommunity

for

Search:↓

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

No single treatment is consistently effective for alopecia areata, and more research is needed.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Exosomes could revolutionize skin disease treatment and healing.

Ongoing research and innovation are crucial for improving skin care and treatment.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Generalized pustular psoriasis patients often need strong medication and careful treatment due to flare-ups and complications.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Alopecia areata treatment varies, with no optimal method established yet.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.